BioCatalyst

BHVN — Biohaven Ltd. catalysts

4 verified catalyst event(s) for Biohaven Ltd. (ticker BHVN). Each is linked to its official source. Verified as of 2026-08-06.

Next verified catalyst

2026-09-01 — Taldefgrobep Alfa in Adults With Overweight and Obesity · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09 (month)
in 26d
ESTIMATED
 READOUT
Taldefgrobep Alfa in Adults With Overweight and Obesity
Phase 2 · Obesity, Overweight
 BHVN Biohaven Ltd. Taldefgrobep Alfa, Taldefgrobep Alfa ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
2026-10 (month)
in 2mo
ESTIMATED
 READOUT
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory F
Phase 2/3 · Focal Epilepsy
 BHVN Biohaven Ltd. BHV-7000, BHV-7000 ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
2026-12 (month)
in 4mo
ESTIMATED
 READOUT
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory
Phase 2/3 · Focal Epilepsy
 BHVN Biohaven Ltd. BHV-7000, BHV-7000, BHV-7000 ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
2026-12 (month)
in 4mo
ESTIMATED
 READOUT
Long-term Safety and Tolerability of BHV-7000
Phase 2 · Focal Epilepsy
 BHVN Biohaven Ltd. BHV-7000, BHV-7000 ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.